🇺🇸 FDA
Pipeline program

Tests of the expression of CXCL3 in various tissues

2024-695

Unknown other completed

Quick answer

Tests of the expression of CXCL3 in various tissues for Diabetic Kidney Disease (DKD) is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Diabetic Kidney Disease (DKD)
Phase
Unknown
Modality
other
Status
completed

Clinical trials